Article Details
Retrieved on: 2021-10-01 20:26:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
LONDON and NOVATO, Calif., Oct. 01, 2021 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (Nasdaq: RARE), a biopharmaceutical company focused on the ...
Article found on: finance.yahoo.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here